References
- Cancer Res. v.61 Attenuation of Doxorubicin chronic toxicity in metallothionein-overerpressing transgenic mouse heart. Sun, X.;Zheu, Z;Kang, Y. J.
- Oncol v.19 The anthracyclines: will we ever find a better Doxorubicin Semin Weiss, R.B.
- J. Am. Med. Assoc. v.266 Cardiac toxicity 4 to 20 years after completing anthracycline therapy. Steinherz, L.J.;Steinherz, P.G.;Tan, C.T.;Heller, C.;Murphy. M.L.
- Hum. Exp.Toxicol. v.11 Preclinical toxicology of a noveklpolymeric antitumour agent. HPMA copolymer-Doxorubicin(PK 1 ). Duncan, R.;Coatsworth, J.K.;Burtles, S.
- 동서의학결합치료2 암 문구;정병학;김병주
- In Vivo v.7 Preclinical toxicology study of liposome encapsulated Doxorubicin(TLC D-99). comparison wlth Doxorubicin and empty liposome in mice and dogs. Kanter, P. M.;Builard, G. A.;Pilkiewicz, F.G.;Mayer, L. D.;Cuilis, P. R.;Pavelic,Z.P.
- Eur. J. Pharmacol v.414 Cardioprotective effects of zofenopril, a newangiotensin-converting enzyme inhibitor, on Doxorubicin-induced cardiotoxicity in the rat. Sacco, C.;Blglonl, M.;Evangellsta, S.;Goso, C.;Manzlni, S.;Maggl, C.A.
- Anticancer Drug Des. v.15 Prevention of adriamycin-induced mdrlgene amplification and expression in mouse leukemia cells by simultaneous treatment with the anti-recombinogen bromovinyl-deoxyuridine. Fahrig, R.;Steinkamp-Zucht, A.;Schaefer, A.
- 半邊蓮과 항암제의 B16-F0 melanoma cell에 대한 항종양 효과 張熙一
- 抗癌生血湯이 Methotrexate로 유발된 부작용과 면역기능 저하에 미치는 영향 李峻溶
- 少陰人補中益氣湯과 少陰人補中益氣湯加味方의 항암효과 및 Cyclophosphomide에 의한 부작용에 미치는 영향 郭桂豪
- 金궤票略註釋 李克光
- 半夏瀉心湯의 效能에 관한 실험적연구 朴治洙
- 半夏瀉心湯과 cimetidine의 병용투여가 흰쥐의 위궤양에 미치는 영향 복진우
- 半夏瀉心湯 및 半夏瀉心湯加赤石胎가 實驗的 胃潰瘍에 미치는 영향 조남수
- 本草學 v.3 全國韓醫科大學 本草學敎室
- 방제학 李尙仁;金東傑;金永坂;盧昇鉉;朴宣東;李暎鍾;周榮丞
- Toxicol. Sci. v.60 Single-dosed toxicity study of hepatic intra-arterial infusion of Doxorubicin coupled to a novel magnetically targeted drug carrier Goodwin, S. C.;Bittner, C. A.;Peterson, C.L.;Wong G.
- Res. Commun. Chem. Pathol. Pharmacol. v.74 The effect of chronic administeration of Doxorubicin on the rat cardiac and hepatic glutathion redox system Powell, S. R.;Chevion, M.
- Cancer Res. v.47 Effect of allyl alcohol-induced sublethal hepatic damage upon Doxorubicin metabolism and toxicity in the rabbit Brenner, D. E.;Anthony, L. B.;Halter, S.;Harris, N. L.;Collins, J. C.;Hande, K. R.(etc).
- J. A. M. A. v.256 Subclinical hepatic toxicity during combination chemotherapy for breast cancer Larroquette, C.A.;Hortobagyi, G.N.;Buzdar, A.U.;Holmes, F.A.
- Arch. Pathol. Lab. Med. v.108 Hepatic injury during Doxorubicin therapy Aviles, A.;Herrera, J.;Ramos. E.;Ambriz,R.;Aguirre, J.;Pizzuto, J.
- Acta. Physiol. Hung. v.64 Inhibition of Doxorubicin-induced liver toxicity by a new dihydroquinoline type antioxidant Sreter, I.;Kiss, A.;Comides, A.;Vereckei, A.;Toncsev, H.;Feher, J.
- Small animal clinical diagnosis by laboratory methods v.1 Willard, M.D.
- Phytomedicine v.7 Treatment of chemotherapy-induced leukopenia in a rat model with aqueous extract from Uncaria tomentosa Sheng, Y.;Pero, R. W.;Wagner, H.
- Toxicol. Pathol. v.22 BR96-Doxorubicin conjugate(BMS-182248) versus Doxorubicin: a comparative toxicity assessment in rats. Comereski, C.R.;Peden. W.M.;Davidson, T.J.;Warner, G.L.;Hirth, R.S.;Frantz, J.D.
- J. Pharmacol. Exp. Ther. v.92 Metallothionein act as a cytoprotectant against Doxorubicin toxicity Kimura, T.;Fujita I.;Itoh, N.;Muto, N.;Nakanishi, T.;Takahashi, K.(etc.)
- Toxicology v.95 Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage,and enhanced excretion of urinary lipldmetabolites in rats Bagchi. D.;Bgchi, M.;Hassoun,E. A.;Kelly,J.;Stohs,S. J.
- Tumori v.86 Modulatory effects of melatonin and vitamine E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Wahab, M. H.;Akoul, E. S.;Abdel-Aziz, A.A..